Trial Profile
AJH801 Phase III Comparative Clinical Study in individuals with essential hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Cilnidipine/valsartan (Primary) ; Cilnidipine; Valsartan
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Ajinomoto Pharma
- 25 May 2016 New trial record